Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Metabolism: Clinical and Experimental|September 14, 2001
FABP2 genotype is associated with insulin sensitivity in older womenM D Brown, A R Shuldiner, R E Ferrell, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1993
Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfectaS D Chipman, H O Sweet, D J McBride, et al.
Diabetes/Metabolism Research and Reviews|October 12, 2000
Molecular scanning for mutations in the insulin receptor substrate-1 (IRS-1) gene in Mexican Americans with Type 2 diabetes mellitusF S Celi, C Negri, K Tanner, et al.
Journal of Thrombosis and Haemostasis : JTH|October 13, 2009
The effect of elinogrel on high platelet reactivity during dual antiplatelet therapy and the relation to CYP2C19*2 genotype: first experience in patientsP A Gurbel, K P Bliden, M J Antonino, et al.
Bone|June 17, 2008
Autosome-wide linkage analysis of hip structural phenotypes in the Old Order AmishE A Streeten, T J Beck, J R O'Connell, et al.
Clinical Pharmacology and Therapeutics|May 24, 2013
Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 updateS A Scott, K Sangkuhl, C M Stein, et al.
Journal of Thrombosis and Haemostasis : JTH|July 2, 2013
The CYP2C19*17 variant is not independently associated with clopidogrel responseJ P Lewis, S H Stephens, R B Horenstein, et al.
The Journal of Clinical Endocrinology and Metabolism|March 10, 2001
Genome-wide scan of obesity in the Old Order AmishW C Hsueh, B D Mitchell, J L Schneider, et al.
Clinical Pharmacology and Therapeutics|July 11, 2013
Purine pathway implicated in mechanism of resistance to aspirin therapy: pharmacometabolomics-informed pharmacogenomicsL M Yerges-Armstrong, S Ellero-Simatos, A Georgiades, et al.
Pageof 10